Literature DB >> 2682652

Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer disease.

S Lehéricy1, E C Hirsch, P Cervera, L B Hersh, J J Hauw, M Ruberg, Y Agid.   

Abstract

Cholinergic neurons were studied by immunohistochemistry with an antiserum against human choline acetyltransferase in the caudate nucleus, putamen, and ventral striatum (including the nucleus accumbens) of three patients with Alzheimer disease and three control subjects. Immunoreactive cell bodies were mapped and counted. In the ventral striatum of patients with Alzheimer disease, a 60% decrease in the number of cholinergic neurons was observed, whereas in the caudate nucleus and putamen values for control subjects and patients were similar. To determine whether all neurons in the ventral striatum were affected, neuropeptide Y-containing neurons were also immunostained, mapped, and counted. The number of these neurons was the same in control subjects and patients with Alzheimer disease, indicating that neuronal loss is not generalized in the ventral striatum and may be specific to the cholinergic population.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2682652      PMCID: PMC298326          DOI: 10.1073/pnas.86.21.8580

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.

Authors:  R C Pearson; M M Esiri; R W Hiorns; G K Wilcock; T P Powell
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

Review 2.  Alzheimer's disease: a multisystem disorder.

Authors:  D L Price; R G Struble; P J Whitehouse; C A Kitt; L C Cork; L C Walker; M F Casanova
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1986

3.  Olfactory tubercle choline acetyltransferase activity in Alzheimer-type dementia, Down's syndrome and Huntington's chorea.

Authors:  J Simpson; C M Yates; A Gordon; D M St Clair
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-10       Impact factor: 10.154

4.  Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry.

Authors:  M M Mesulam; E J Mufson; A I Levey; B H Wainer
Journal:  Neuroscience       Date:  1984-07       Impact factor: 3.590

5.  Immunoaffinity purification of human choline acetyltransferase: comparison of the brain and placental enzymes.

Authors:  G Bruce; B H Wainer; L B Hersh
Journal:  J Neurochem       Date:  1985-08       Impact factor: 5.372

6.  Distribution of central cholinergic neurons in the baboon (Papio papio). I. General morphology.

Authors:  K Satoh; H C Fibiger
Journal:  J Comp Neurol       Date:  1985-06-08       Impact factor: 3.215

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Immunohistochemical staining of cholinergic neurons in the human brain using a polyclonal antibody to human choline acetyltransferase.

Authors:  D C German; G Bruce; L B Hersh
Journal:  Neurosci Lett       Date:  1985-10-24       Impact factor: 3.046

9.  Selective involvement of large neurons in the neostriatum of Alzheimer's disease and senile dementia: a morphometric investigation.

Authors:  K Oyanagi; H Takahashi; K Wakabayashi; F Ikuta
Journal:  Brain Res       Date:  1987-05-19       Impact factor: 3.252

10.  Differences in tyrosine hydroxylase-like immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturity.

Authors:  A M Graybiel; E C Hirsch; Y A Agid
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

View more
  17 in total

1.  Ventral striatal volume is associated with cognitive decline in older people: a population based MR-study.

Authors:  L W de Jong; Y Wang; L R White; B Yu; M A van Buchem; L J Launer
Journal:  Neurobiol Aging       Date:  2010-11-13       Impact factor: 4.673

Review 2.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

Review 3.  Pain in people with Alzheimer disease: potential applications for psychophysical and neurophysiological research.

Authors:  Todd B Monroe; John C Gore; Li Min Chen; Lorraine C Mion; Ronald L Cowan
Journal:  J Geriatr Psychiatry Neurol       Date:  2012-12-31       Impact factor: 2.680

4.  Different levels of acetylcholinesterase and choline acetyltransferase activities in C57Bl/6 and DBA/2 mice are not accompanied with different density of cortical acetylcholinesterase reactive fibers.

Authors:  C Schwab; G Brückner; C Castellano; A Oliverio; D Biesold
Journal:  Neurochem Res       Date:  1990-11       Impact factor: 3.996

5.  Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: an in situ hybridization study.

Authors:  O Strada; S Vyas; E C Hirsch; M Ruberg; A Brice; Y Agid; F Javoy-Agid
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

6.  Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.

Authors:  Sylvia E Perez; Saleem Dar; Milos D Ikonomovic; Steven T DeKosky; Elliott J Mufson
Journal:  Neurobiol Dis       Date:  2007-06-27       Impact factor: 5.996

7.  The neostriatum and nucleus accumbens in parkinsonism-dementia complex of Guam: a pathological comparison with Alzheimer's disease and progressive supranuclear palsy.

Authors:  K Oyanagi; T Makifuchi; T Ohtoh; K M Chen; D C Gajdusek; T N Chase; F Ikuta
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: a potential diagnostic biochemical marker.

Authors:  D Gunnersen; B Haley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  Targeting selective activation of M(1) for the treatment of Alzheimer's disease: further chemical optimization and pharmacological characterization of the M(1) positive allosteric modulator ML169.

Authors:  James C Tarr; Mark L Turlington; Paul R Reid; Thomas J Utley; Douglas J Sheffler; Hyekyung P Cho; Rebecca Klar; Tristano Pancani; Michael T Klein; Thomas M Bridges; Ryan D Morrison; Anna L Blobaum; Zixui Xiang; J Scott Daniels; Colleen M Niswender; P Jeffrey Conn; Michael R Wood; Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2012-07-18       Impact factor: 4.418

10.  The Dementia Rating Scale in Alzheimer's disease, Huntington's disease and progressive supranuclear palsy.

Authors:  A E Rosser; J R Hodges
Journal:  J Neurol       Date:  1994-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.